Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.

I would appreciate your thoughts on what might happen should it be determined that Barco/Acer/HTC do not infringe on the MMP portfolio. Will that in effect mean that the true value of the portfolio will be diminished to the point where the following provision of the ComAg could be effected. Should we prevail, would that in and of itself mean that there has been no material reduction in the commercial value of the patents?

5.2 In the event that facts or events are discovered or occur which

materially reduce TPL's evaluation of the useful life or commercial value of the

MSD Patents, or the viability of the Project, TPL may reduce the term of this

Commercialization Agreement accordingly by providing P-Newco with ninety (90)

days written notice, provided that TPL shall not reduce the term of this

Commercialization Agreement to less than six (6) months.

Please login to post a reply
l2007s
City
Rank
President
Activity Points
18126
Rating
Your Rating
Date Joined
04/27/2007
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post